The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[3-fluoro-4-[3-(4-piperidyl)propoxy]phenyl]-1-methyl-pyrazolo[3,4-d]pyrimidin-6-amine ID: ALA4755173
PubChem CID: 129073113
Max Phase: Preclinical
Molecular Formula: C20H25FN6O
Molecular Weight: 384.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1nc(-c2ccc(OCCCC3CCNCC3)c(F)c2)c2cnc(N)nc21
Standard InChI: InChI=1S/C20H25FN6O/c1-27-19-15(12-24-20(22)25-19)18(26-27)14-4-5-17(16(21)11-14)28-10-2-3-13-6-8-23-9-7-13/h4-5,11-13,23H,2-3,6-10H2,1H3,(H2,22,24,25)
Standard InChI Key: YSLSSCOTQRLGCR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
28.9800 -18.1515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9788 -18.9752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6910 -19.3841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4048 -18.9747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4020 -18.1479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6892 -17.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1123 -17.7325 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.1173 -19.3822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.8243 -18.9725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5368 -19.3800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2480 -18.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9605 -19.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9580 -20.1996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6664 -20.6111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3800 -20.2007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.3807 -19.3785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6678 -18.9666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2680 -17.7397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1824 -16.9229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.3789 -16.7532 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5174 -18.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9719 -17.4646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1708 -17.6338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9142 -18.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4688 -19.0256 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2679 -18.8533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1110 -18.5853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0458 -16.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
4 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
18 19 2 0
19 20 1 0
20 22 1 0
21 18 1 0
1 18 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
24 27 1 0
20 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.46Molecular Weight (Monoisotopic): 384.2074AlogP: 2.91#Rotatable Bonds: 6Polar Surface Area: 90.88Molecular Species: BASEHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.36CX LogP: 2.65CX LogD: -0.13Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -1.14
References 1. Alper PB,Deane J,Betschart C,Buffet D,Collignon Zipfel G,Gordon P,Hampton J,Hawtin S,Ibanez M,Jiang T,Junt T,Knoepfel T,Liu B,Maginnis J,McKeever U,Michellys PY,Mutnick D,Nayak B,Niwa S,Richmond W,Rush JS,Syka P,Zhang Y,Zhu X. (2020) Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway., 30 (17): [PMID:32738975 ] [10.1016/j.bmcl.2020.127366 ]